Not logged inSequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024
Wu, Pei-Jui; Tsay, Feng-Woei; Wu, Deng-Chyang; Yang, Jyh-Chin; Chuah, Seng-Kee; Chen, Kuan-Yang; Chen, Chien-Lin; Lee, Chia-Long; Shih, Chih-An; Liu, Yu-Hwa; Shiu, Sz-Iuan; Tai, Wei-Chen; Kuo, Chao-Hung; Lei, Wei-Yi; Kao, Sung-Shuo; Tsai, Tzung-Jiun; Feng, I-Che; Koseki, Mitsuhiro; Hsu, Ping-, I; Sheu, Ming-Jen .png)
Share.png)
SaveIndependent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori InfectionChen, Chien-Lin; Wu, I-Ting; Wu, Deng-Chyang; Lei, Wei-Yi; Tsay, Feng-Woei; Chuah, Seng-Kee; Chen, Kuan-Yang; Yang, Jyh-Chin; Liu, Yu-Hwa; Kuo, Chao-Hung; Shiu, Sz-Iuan; Shie, Chang-Bih; Lin, Kuan-Hua; Lee, Chia-Long; Hsu, Ping-, I Share Save Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized TrialHsu, Ping-, I; Chen, Kuan-Yang; Tai, Wei-Chen; Yang, Jyh-Chin; Tsay, Feng-Woei; Liu, Yu-Hwa; Chen, Chien-Lin; Lee, Chia-Long; Yeh, Hong-Zen; Kuo, Chao-Hung; Chuah, Seng-Kee; Lee, Hsi-Chang; Shie, Chang-Bih; Shiu, Sz-Iuan; Kao, John Y.; Yamaoka, Yoshio; Graham, David Y.; Wu, Deng-Chyang Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
